673 P P (Cabergoline 0.5 mg)
Pill with imprint 673 P P is White, Elliptical / Oval and has been identified as Cabergoline 0.5 mg. It is supplied by Par Pharmaceutical Inc..
Cabergoline is used in the treatment of hyperprolactinemia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Cabergoline 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 673 P P
Cabergoline
- Imprint:
- 673 P P
- Strength:
- 0.5 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
Prolactin inhibitors - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Par Pharmaceutical Inc.
- Inactive Ingredients:
- citric acid
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
Note: Inactive ingredients may vary.
More about cabergoline
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 48 Reviews – Add your own review/rating
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
Other brands: Dostinex
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
